Mithra Pharmaceuticals S.A.

Board/Management Information • Apr 25, 2023

Christian Moretti Private Equity – Investor – Advisor

I - BUSINESS EXPERIENCE

ANBLAN - Family Office Chairman (July 1995 – January 2019)

QUANTEL - Listed Company, world leader in industrial lasers Chairman (January 2011 - June 2017 – 6 years and 6 months)

PCAS

Chairman (2004 - 2017 – 13 years)

Specializes in the development and production of complex molecules for life sciences and innovative technologies. The company offers a growing range of proprietary products and solutions in leading edge segments. PCAS generated net sales of €206.7 million in 2018 and employs close to 1100 people in six countries. PCAS was taken over by NOVACAP in June 2017.

UIC – Union des Industries chimiques (now renamed France Chimie) Elected to the Board (2004 – 2012 – 8 years) French Trade Association representing the chemical industry.

CEFIC - European Chemical Industry Council (2006 – 2012 – 6 years) Elected representative of UIC and therefore represented France at this European Chemical Association

DYNACTION - Listed Company – Diversified Industrial Holding Company

Chairman and co-founder (1983 - 2017 – 34 years)

Founded in 1983 by Henri Blanchet et Christian Moretti, Dynaction started from nothing by acquiring the French subsidiary of a US conglomerate for a nominal value (1 Franc) and turning it around in less than six months.

From that healthy base, Dynaction started buying non core business subsidiaries of large

Industrial group located in France. Bringing Private Equity to main stream Europe, It incentivised the management teams up to 25% of the equity of the targets with the aim to list them on the "Second Marché" in order to réalise substantial capital gains. A text book win-win-win.

Dynaction, at its peak, oversaw 74 companies.

After the premature death of Henri in 1995, Christian took the difficult decision to focus Dynaction around one of its strategic subsidiaries: PCAS.

Dynaction merged with the fine chemicals specialist and expanded its reach into life sciences. A friendly take over by Novacap of PCAS valued the company at over 230 million euros.

II - TEACHING

ESCP Europe

Professor of Finance (Finance, Banking and Stock Market) at ESCP Europe (1975 to 1983 – 8 years)

III- BOARD MEMBER (Current)

• ENERSENS
• MITHRA PHARMACEUTICALS (Chairman) Belgium
• XERYS (Capital Luxembourg)
• SELVA Luxembourg

IV - EDUCATION

Columbia Business School (MBA) 1970 - 1971 Master of Business Administration (M.B.A.)

HEC 1966 – 1969 Master's degree – Option : Marketing and Finance

V – LANGUAGES: French – English – Italian

VI – HOBBIES: Golf, Tennis, Cinema, Travel